Item 8.01 Other Events.
OnJanuary 19, 2021 ,Salarius Pharmaceuticals, Inc. (the "Company") received notice fromListing Qualifications Department (the "Staff") of theNasdaq Stock Market confirming that the Staff has determined that for the last 10 consecutive business days, fromJanuary 4 to January 15, 2021 , the closing bid price of the Company's common stock has been at$1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and it has indicated to the Company that this matter is now closed.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. Exhibit Number Description Press Release Announcing Salarius Pharmaceuticals Regain s Compliance with Nasdaq Minimum Bid Price Listing Requirement, dated January 99.1 21, 2021
--------------------------------------------------------------------------------
© Edgar Online, source